ReviewFrontiers in immunology2024

From standard therapies to monoclonal antibodies and immune checkpoint inhibitors - an update for reconstructive surgeons on common oncological cases.

Leonard Knoedler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.